Case report details a rare genetic eye disease linked to mutations in the abca4 gene, suggesting future research in gene therapy.
Stargardt’s macular dystrophy (SMD) is an autosomal recessive inherited retinal dystrophy associated with a mutation in the ABCA4 gene. Although there are no current food and drug administration (FDA)-approved treatments or cures for patients with SMD, current research avenues include nutritional supplementation, drug therapies, and gene therapy. It is a rare genetic eye disease that happens when fatty material builds upon the macula.
No takes yet. Share an insight, caveat, or question.
Rajnandani et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: